Device Trial Radar · NCT06496763
Assessment of an Automated Optical Coherence Tomography and Camera : Effectiveness of Vision-700
Last checked: Nov 19, 2026Latest source record: Jul 11, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
159
Actual
Start
Sep 1, 2022
Primary completion
Sep 1, 2022
Study completion Jul 31, 2023
Sponsor
- Lead sponsor
- Crystalvue Medical CoporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 11, 2024
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of study is to assess the repeatability and agreement of the retina and cornea measurement by Vision-700 in comparison with those by 3D OCT-1.
Conditions
- Normal Subject
- Glaucoma
- Retinal Disease
- Cornea
Interventions
Vision-700Device
OCT machines used for diagnostic purposes
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Precision of Vision-700 in Retinal and Cornea MeasurementTime frame: 2022/9/1
- The Precision of 3D OCT-1 in Retinal and Cornea MeasurementsTime frame: 2022/9/1
- The Agreement of Vision-700 and 3D OCT-1 in Retinal and Cornea MeasurementsTime frame: 2022/9/1
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Tri-Services General Hospital
Taipei County, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.